Illumina Ventures to Launch Illumina® Ventures Labs
Illumina Ventures, a leading genomics and precision health venture firm, today announced plans to launch Illumina® Ventures Labs.
Attovia Therapeutics Launches With $60 Million Series A Financing To Unlock Potential Of Novel Biparatopic Nanobody Platform
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of diseases, and Frazier Life Sciences, announced the launch of Attovia Therapeutics, a newly formed company focused on creating a pipeline of biotherapeutics in immune-mediated disease and cancer.
Pluton Biosciences Raises $16.5M Series A led by Illumina Ventures and RA Capital
Led by Illumina Ventures and RA Capital to discover and deploy microbes that will fight climate change. Illumina Ventures’ Charles Lin, PhD, who has joined Pluton’s Board of Directors, expressed his excitement about the fund’s first AgBio investment, “In the past two decades, we have witnessed how genomics revolutionized the landscape of human diagnostics and therapeutics. We expect genomics to...
Company Spotlight – Sherlock Biosciences
Diagnostic tests are vital, but the current system can be challenging. Blood draw sites are often inconvenient, and patients can wait days for results. In addition, people testing for sexually transmitted diseases (STDs), and other potentially sensitive conditions, may opt-out over privacy concerns.
Sherlock Biosciences is working to address these issues by changing how people access diagnostics.